Home › Companies › PACIRA BIOSCIENCES INC. › 2024-2025

PACIRA BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and PACIRA BIOSCIENCES INC.’s Form 8-K, filed 2025-06-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.

11Reported items
289Asset managers
2,599Fund votes
2025-06-10Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore PACIRA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PACIRA BIOSCIENCES INC.

These tallies are PACIRA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PACIRA BIOSCIENCES INC. — official shareholder meeting results, meeting held 2025-06-10
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Marcelo Bigal	33,364,221	--	--	4,017,587	8,909,022	Majority: yes
Elect Director: Frank D. Lee	32,858,858	--	--	4,522,950	8,909,022	Majority: yes
Elect Director: Alethia Young	28,757,450	--	--	8,624,358	8,909,022	Majority: yes
Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.	40,022,569	352,947	20,917	--	--	Majority: yes
Proposal 3: Advisory vote to approve the compensation of the Company's named executive officers.	14,752,829	22,595,202	33,777	--	8,909,022	Majority: no
Proposal 5: Approval of the Company's Amended and Restated 2011 Stock Incentive Plan.	22,043,902	15,317,588	20,318	--	8,909,022	Majority: yes

Source: PACIRA BIOSCIENCES INC., Form 8-K, filed with the SEC on 2025-06-13 — read the filing on EDGAR.

How asset managers voted at the PACIRA BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 289 asset managers that disclosed a PACIRA BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PACIRA BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on an advisory basis, of the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: no

Meeting held 2025-06-10.

Combines 7 wordings of this item as funds reported it.

40% Majority: no · of votes cast

FOR 40%AGAINST 60%

FOR: 14,752,829AGAINST: 22,595,202

PACIRA BIOSCIENCES INC.’s own tally for this item (“Proposal 3: Advisory vote to approve the compensation of the Company's named executive officers.”): 14,752,829 for, 22,595,202 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,283,407 outstanding shares: 32% for, 48.8% against (81% of the company cast a for/against vote).

The 285 asset managers below cast 45% of the shares they voted on this item FOR (16,423,490 for, 20,264,615 against).

FOR 45%AGAINST 55%

FOR: 16,423,490 (44.7%)AGAINST: 20,264,615 (55.2%)ABSTAIN: 15,884 (0.0%)

Largest asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
BlackRock	642,195	6,532,937	Against
Vanguard	5,536,826	25,051	For
State Street	1,857,181	24,555	For
American Century	0	1,420,914	Against
Alyeska Investment Group, L.P.	0	1,285,660	Against
Fidelity	1,216,312	27,448	For
Renaissance	0	1,177,924	Against
GEODE CAPITAL MANAGEMENT, LLC	1,148,776	0	For
Charles Schwab	0	999,997	Against
Invesco	0	884,265	Against
Dimensional	0	640,528	Against
Pacer Funds Trust	536,616	0	For
IMPAX ASSET MANAGEMENT LLC	520,027	0	For
IMPAX FUNDS SERIES TRUST I	520,027	0	For
Nuveen	0	518,482	Against
TIAA	0	511,981	Against
BALYASNY ASSET MANAGEMENT L.P.	509,972	0	For
JPMorgan	495,567	0	For
J. Goldman & Co LP	473,813	0	For
DE Shaw	0	435,843	Against
Northern Trust	0	425,431	Against
Wellington	421,122	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	0	370,521	Against
Columbia Threadneedle	0	359,798	Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC	0	331,854	Against

Showing the 25 largest of 285 asset managers. See all 285 in the interactive database.

2. Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-10.

Combines 3 wordings of this item as funds reported it.

29% fund support · no official result

ONE YEAR 58%1 YEAR 40%

The 275 asset managers below cast 29% of the shares they voted on this item FOR (24,608 for, 59,771 against).

FOR: 24,608 (0.1%)AGAINST: 59,771 (0.2%)ABSTAIN: 4,362 (0.0%)ONE YEAR: 20,832,645 (57.7%)1 YEAR: 14,443,573 (40.0%)THREE YEARS: 655,119 (1.8%)3 YEARS: 56,749 (0.2%)1-YEAR: 3,780 (0.0%)3 YEAR: 4 (0.0%)2 YEAR: 0 (0.0%)

Largest asset managers voting on “Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named execu” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
BlackRock	0	0	0	0	1 Year
Vanguard	0	0	0	0	One Year
State Street	0	0	0	0	One Year
American Century	0	0	0	0	One Year
Alyeska Investment Group, L.P.	0	0	0	0	One Year
Fidelity	0	0	0	0	One Year
Renaissance	0	0	0	0	One Year
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	One Year
Charles Schwab	0	0	0	0	1 Year
Invesco	0	0	0	0	One Year
Dimensional	0	0	0	0	Three Years
Pacer Funds Trust	0	0	0	0	1 Year
IMPAX ASSET MANAGEMENT LLC	0	0	0	0	1 Year
IMPAX FUNDS SERIES TRUST I	0	0	0	0	1 Year
Nuveen	0	0	0	0	One Year
TIAA	0	0	0	0	One Year
BALYASNY ASSET MANAGEMENT L.P.	0	0	0	0	1 Year
J. Goldman & Co LP	0	0	0	0	1 Year
DE Shaw	0	0	0	0	One Year
Northern Trust	0	0	0	0	1 Year
Wellington	0	0	0	0	1 Year
JACOBS LEVY EQUITY MANAGEMENT, INC	0	0	0	0	1 Year
Columbia Threadneedle	0	0	0	0	One Year
PARAMETRIC PORTFOLIO ASSOCIATES LLC	0	0	0	0	One Year
SEI	0	0	0	0	1 Year

Showing the 25 largest of 275 asset managers. See all 275 in the interactive database.

3. APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-06-10.

Combines 4 wordings of this item as funds reported it.

59% Majority: yes · of votes cast

FOR 59%AGAINST 41%

FOR: 22,043,902AGAINST: 15,317,588

PACIRA BIOSCIENCES INC.’s own tally for this item (“Proposal 5: Approval of the Company's Amended and Restated 2011 Stock Incentive Plan.”): 22,043,902 for, 15,317,588 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,283,407 outstanding shares: 47.6% for, 33% against (81% of the company cast a for/against vote).

The 93 asset managers below cast 79% of the shares they voted on this item FOR (15,111,634 for, 4,044,786 against).

FOR 79%AGAINST 21%

FOR: 15,111,634 (78.8%)AGAINST: 4,044,786 (21.1%)ABSTAIN: 10,119 (0.1%)

Largest asset managers voting on “APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	5,375,664	16,032	For
BlackRock	5,198,532	0	For
Fidelity	1,146,758	7,345	For
American Century	0	685,699	Against
Pacer Funds Trust	0	536,616	Against
State Street	523,770	682	For
IMPAX FUNDS SERIES TRUST I	520,027	0	For
TIAA	511,981	0	For
Charles Schwab	470,353	0	For
Dimensional	0	462,129	Against
Columbia Threadneedle	0	359,798	Against
Invesco	0	348,544	Against
DWS	0	257,131	Against
EA Series Trust	229,057	0	For
JPMorgan	201,612	0	For
Simplify Exchange Traded Funds	133,347	0	For
Nationwide	1,322	127,543	Against
SEI	128,110	0	For
Equitable	73,626	51,500	For
Victory Capital	0	115,745	Against
Jackson National	0	91,685	Against
Northern Trust	0	88,250	Against
GuideStone	0	79,587	Against
QUANTITATIVE MASTER SERIES LLC	78,475	0	For
AIG/SunAmerica	0	74,986	Against

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

4. RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-06-10.

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 40,022,569AGAINST: 352,947

PACIRA BIOSCIENCES INC.’s own tally for this item (“Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”): 40,022,569 for, 352,947 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,283,407 outstanding shares: 86% for, 0.8% against (87% of the company cast a for/against vote).

The 92 asset managers below cast 99% of the shares they voted on this item FOR (18,888,450 for, 273,711 against).

FOR 99%

FOR: 18,888,450 (98.5%)AGAINST: 273,711 (1.4%)ABSTAIN: 4,354 (0.0%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	5,391,695	1	For
BlackRock	5,198,532	0	For
Fidelity	1,154,103	0	For
American Century	685,699	0	For
Pacer Funds Trust	536,616	0	For
State Street	524,420	32	For
IMPAX FUNDS SERIES TRUST I	520,027	0	For
TIAA	511,981	0	For
Charles Schwab	470,353	0	For
Dimensional	462,129	0	For
Columbia Threadneedle	359,798	0	For
Invesco	348,544	0	For
DWS	257,131	0	For
EA Series Trust	0	229,057	Against
JPMorgan	201,612	0	For
Simplify Exchange Traded Funds	133,347	0	For
Nationwide	128,865	0	For
SEI	128,110	0	For
Equitable	125,126	0	For
Victory Capital	115,745	0	For
Jackson National	91,685	0	For
Northern Trust	88,250	0	For
GuideStone	79,587	0	For
QUANTITATIVE MASTER SERIES LLC	78,475	0	For
AIG/SunAmerica	74,986	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

5. Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Alethia Young

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-10.

Combines 3 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%WITHHELD 23%

FOR: 28,757,450WITHHELD: 8,624,358

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Alethia Young”): 28,757,450 for, 8,624,358 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,283,407 outstanding shares: 62% for, 19% withheld (81% of the company cast a for/withheld vote).

The 89 asset managers below cast 100% of the shares they voted on this item FOR (16,876,755 for, 0 against).

FOR 89%11%

FOR: 16,876,755 (88.9%)ABSTAIN: 2,111,513 (11.1%)

Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,389,423	2,273	For
BlackRock	4,964,857	233,675	For
Fidelity	1,133,526	20,577	For
American Century	685,699	0	For
Pacer Funds Trust	536,616	0	For
State Street	2,066	522,386	Abstain
IMPAX FUNDS SERIES TRUST I	520,027	0	For
TIAA	511,981	0	For
Charles Schwab	0	470,353	Abstain
Dimensional	0	462,129	Abstain
Columbia Threadneedle	359,798	0	For
Invesco	348,544	0	For
DWS	257,131	0	For
EA Series Trust	229,057	0	For
JPMorgan	201,612	0	For
Nationwide	128,865	0	For
SEI	0	128,110	Abstain
Equitable	73,626	51,500	For
Victory Capital	115,745	0	For
Jackson National	79,722	11,963	For
Northern Trust	88,250	0	For
GuideStone	79,587	0	For
QUANTITATIVE MASTER SERIES LLC	78,475	0	For
AIG/SunAmerica	74,986	0	For
Hartford	74,861	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

6. Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Frank D. Lee

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-10.

Combines 3 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%

FOR: 32,858,858WITHHELD: 4,522,950

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Frank D. Lee”): 32,858,858 for, 4,522,950 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,283,407 outstanding shares: 71% for, 10% withheld (81% of the company cast a for/withheld vote).

The 89 asset managers below cast 100% of the shares they voted on this item FOR (18,483,844 for, 0 against).

FOR 97%

FOR: 18,483,844 (97.3%)ABSTAIN: 504,424 (2.7%)

Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,391,686	10	For
BlackRock	5,198,532	0	For
Fidelity	1,154,103	0	For
American Century	685,699	0	For
Pacer Funds Trust	536,616	0	For
State Street	524,452	0	For
IMPAX FUNDS SERIES TRUST I	520,027	0	For
TIAA	511,981	0	For
Charles Schwab	470,353	0	For
Dimensional	0	462,129	Abstain
Columbia Threadneedle	359,798	0	For
Invesco	348,544	0	For
DWS	257,131	0	For
EA Series Trust	229,057	0	For
JPMorgan	201,612	0	For
Nationwide	128,865	0	For
SEI	128,110	0	For
Equitable	125,126	0	For
Victory Capital	115,745	0	For
Jackson National	79,722	11,963	For
Northern Trust	88,250	0	For
GuideStone	79,587	0	For
QUANTITATIVE MASTER SERIES LLC	78,475	0	For
AIG/SunAmerica	74,986	0	For
Hartford	74,861	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

7. Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Marcelo Bigal

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-10.

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 33,364,221WITHHELD: 4,017,587

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Marcelo Bigal”): 33,364,221 for, 4,017,587 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,283,407 outstanding shares: 72% for, 9% withheld (81% of the company cast a for/withheld vote).

The 89 asset managers below cast 100% of the shares they voted on this item FOR (17,879,433 for, 0 against).

FOR 94%

FOR: 17,879,433 (94.2%)ABSTAIN: 1,108,835 (5.8%)

Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,391,690	6	For
BlackRock	5,198,532	0	For
Fidelity	1,154,103	0	For
American Century	685,699	0	For
Pacer Funds Trust	536,616	0	For
State Street	2,066	522,386	Abstain
IMPAX FUNDS SERIES TRUST I	520,027	0	For
TIAA	511,981	0	For
Charles Schwab	470,353	0	For
Dimensional	0	462,129	Abstain
Columbia Threadneedle	359,798	0	For
Invesco	348,544	0	For
DWS	257,131	0	For
EA Series Trust	229,057	0	For
JPMorgan	201,612	0	For
Nationwide	128,865	0	For
SEI	128,110	0	For
Equitable	73,626	51,500	For
Victory Capital	115,745	0	For
Jackson National	79,722	11,963	For
Northern Trust	88,250	0	For
GuideStone	79,587	0	For
QUANTITATIVE MASTER SERIES LLC	78,475	0	For
AIG/SunAmerica	74,986	0	For
Hartford	74,861	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

8. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-10.

— fund support · no official result

ONE YEAR 100%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 403,780 (100.0%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
JPMorgan	0	0	0	0	One Year
GuideStone	0	0	0	0	One Year
Empower	0	0	0	0	One Year
CLEARWATER INVESTMENT TRUST	0	0	0	0	One Year
MILLER HOWARD INVESTMENTS INC /NY	0	0	0	0	One Year

9. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-10.

100% fund support · no official result

FOR 99.9%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (178,247 for, 0 against).

FOR: 178,247 (100.0%)1 YEAR: 16 (0.0%)

Largest asset managers voting on “14A Executive Compensation Vote Frequency” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Vote
Simplify Exchange Traded Funds	133,347	For
James Alpha Funds Trust	44,900	For
Focus Partners Wealth	0	1 Year

10. Election of Directors (Majority Voting)

DIRECTOR ELECTIONS

Meeting held 2025-06-10.

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%

Largest asset managers voting on “Election of Directors (Majority Voting)” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Simplify Exchange Traded Funds	133,347	0	0	0	For
James Alpha Funds Trust	44,900	0	0	0	For

11. Approval, on an advisory basis, of the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-11 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%

FOR: 37,228,983AGAINST: 4,087,635

PACIRA BIOSCIENCES INC.’s own tally for this item (“Proposal 3: Advisory vote to approve the compensation of the Company's named executive officers.”): 37,228,983 for, 4,087,635 against, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,283,407 outstanding shares: 80% for, 9% against (89% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 1,299 against).

AGAINST 100%

AGAINST: 1,299 (100.0%)

Largest asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
COLDSTREAM CAPITAL MANAGEMENT INC	0	1,299	0	0	Against
Echo45 Advisors LLC	0	0	0	0	--

Largest PACIRA BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked by the number of PACIRA BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 46,283,407 shares outstanding at the time of that meeting.

Top PACIRA BIOSCIENCES INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	BlackRock	15.50%
2	Vanguard	12.02%
3	State Street	4.07%
4	American Century	3.07%
5	Alyeska Investment Group, L.P.	2.78%
6	Fidelity	2.69%
7	Renaissance	2.55%
8	GEODE CAPITAL MANAGEMENT, LLC	2.48%
9	Charles Schwab	2.16%
10	Invesco	1.91%

Reported PACIRA BIOSCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

PACIRA BIOSCIENCES INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	16.54%	13F
Vanguard Group	11.33%	13F
Pacer US Small Cap Cash Cows ETF	7.04%	13G
Doma Perpetual Capital Management LLC	6.35%	13D
Pedro Escudero	6.35%	13D
Vanguard Portfolio Management	5.59%	13G
D.E. Shaw	4.89%	13F
Renaissance Technologies	4.84%	13F
Dimensional Fund Advisors	4.43%	13F
State Street	4.28%	13F

Percentages above are of 46,283,407 shares outstanding, as reported by PACIRA BIOSCIENCES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIRA BIOSCIENCES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At PACIRA BIOSCIENCES INC.'s shareholder meeting held 2025-06-10, in the 2024-2025 proxy season, 289 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,599 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers. — FOR was 40% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is not more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PACIRA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-13.

PACIRA BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.